Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment
- PMID: 37517924
- DOI: 10.1016/j.medcli.2023.06.005
Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment
Abstract
Peripheral artery disease (PAD) is a condition related to atherosclerosis affecting >200 million people worldwide, and it increases cardiovascular morbidity (mainly from myocardial infarction and stroke) and mortality. Indeed, PAD patients are classified as patients at very high cardiovascular risk. The most common manifestation of PAD is intermittent claudication, which is associated with reduced mobility and leg pain. Nevertheless, asymptomatic PAD is the most frequent form of PAD worldwide; therefore, it remains underdiagnosed and undertreated. The major risk factors for PAD are smoking, diabetes mellitus, hyperlipidemia, hypertension, overweight/obesity, age, male sex, and black race. Hence, the first and most relevant approach in PAD treatment is lifestyle management, with measures such as smoking cessation, healthy diet, weight loss, and regular physical exercise. This should also be supported by an optimal pharmacological approach including lipid-lowering drugs, antihypertensive drugs, antidiabetic agents, and antithrombotics.
Keywords: Diagnosis; Diagnóstico; Enfermedad arterial periférica; Epidemiology; Epidemiología; Factores de riesgo; Peripheral artery disease; Risk factors; Tratamiento; Treatment.
Copyright © 2023 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.Ann Med. 2010 Mar;42(2):139-50. doi: 10.3109/07853890903521070. Ann Med. 2010. PMID: 20156042 Review.
-
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401. Catheter Cardiovasc Interv. 2008. PMID: 18307227 Review.
-
Medical therapy for peripheral arterial disease.Curr Opin Cardiol. 2012 Nov;27(6):592-7. doi: 10.1097/HCO.0b013e328357428a. Curr Opin Cardiol. 2012. PMID: 23032711 Review.
-
Contemporary Medical Management of Peripheral Artery Disease.Circ Res. 2021 Jun 11;128(12):1868-1884. doi: 10.1161/CIRCRESAHA.121.318258. Epub 2021 Jun 10. Circ Res. 2021. PMID: 34110910 Review.
-
Medical and lifestyle management of peripheral arterial disease.J Vasc Surg. 2018 Nov;68(5):1595-1606. doi: 10.1016/j.jvs.2018.07.027. J Vasc Surg. 2018. PMID: 30360849 Review.
Cited by
-
Hypertension in Patients With Peripheral Artery Disease: An Updated Literature Review.Cureus. 2024 Jun 12;16(6):e62246. doi: 10.7759/cureus.62246. eCollection 2024 Jun. Cureus. 2024. PMID: 39006738 Free PMC article. Review.
-
Association between S100A12 and risk of peripheral arterial disease in patients with dyslipidemia: a cross-sectional study.BMC Cardiovasc Disord. 2025 Apr 24;25(1):313. doi: 10.1186/s12872-025-04752-2. BMC Cardiovasc Disord. 2025. PMID: 40269701 Free PMC article.
-
Trends and Outcomes of Lower Limb Amputation in Patients With Coronary Artery Disease.Cureus. 2025 Feb 15;17(2):e79054. doi: 10.7759/cureus.79054. eCollection 2025 Feb. Cureus. 2025. PMID: 40099099 Free PMC article.
-
Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group.Clin Kidney J. 2025 Apr 7;18(5):sfaf089. doi: 10.1093/ckj/sfaf089. eCollection 2025 May. Clin Kidney J. 2025. PMID: 40599821 Free PMC article. Review.
-
Biomaterial-based vascularization strategies for enhanced treatment of peripheral arterial disease.J Nanobiotechnology. 2025 Feb 12;23(1):103. doi: 10.1186/s12951-025-03140-4. J Nanobiotechnology. 2025. PMID: 39940018 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical